comparemela.com

Latest Breaking News On - Eight ten merger - Page 1 : comparemela.com

Motus GI (NASDAQ:MOTS) Announces Earnings Results

Motus GI (NASDAQ:MOTS – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.88) earnings per share (EPS) for the quarter, reports. The business had revenue of $0.06 million for the quarter. Motus GI Stock Performance NASDAQ MOTS traded down $0.00 on Thursday, hitting $0.09. 16,267 shares of the company’s stock […]

Motus GI (NASDAQ:MOTS) Announces Quarterly Earnings Results

Motus GI (NASDAQ:MOTS – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.88) earnings per share (EPS) for the quarter, reports. The business had revenue of $0.06 million during the quarter. Motus GI Price Performance MOTS traded down $0.00 during trading on Thursday, reaching $0.09. The stock had a trading volume […]

Reviewing SeaStar Medical (NASDAQ:ICU) and Motus GI (NASDAQ:MOTS)

SeaStar Medical (NASDAQ:ICU – Get Free Report) and Motus GI (NASDAQ:MOTS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Volatility & Risk SeaStar Medical has a […]

Motus GI Holdings, Inc (NASDAQ:MOTS) Short Interest Update

Motus GI Holdings, Inc. (NASDAQ:MOTS – Get Free Report) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 66,800 shares, a drop of 42.3% from the November 15th total of 115,800 shares. Currently, 10.8% of the shares of the stock are short sold. Based on an […]

Financial Contrast: Monogram Orthopaedics (NASDAQ:MGRM) vs Motus GI (NASDAQ:MOTS)

Motus GI (NASDAQ:MOTS – Get Free Report) and Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Institutional & Insider Ownership 8.6% of Motus […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.